Hormone replacement therapy and breast cancer risk.
Melnikow
J
J
Department of Family Medicine, University of California at Davis, Sacramento, USA.
D001943:Breast Neoplasms / Q000139:chemically induced*; D016022:Case-Control Studies; D015331:Cohort Studies; D004338:Drug Combinations; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006801:Humans; D011372:Progestins / Q000009:adverse effects*; D015203:Reproducibility of Results; D012306:Risk
D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP); D011372:Progestins